“…When indicated, in vivo/in vitro allergy or immunology testing was performed, in order to identify specific sensitizations to vaccine components, according to recommended procedures. 7,8 Finally, a conclusive report was released to the PHU physician, containing indications for subsequent vaccination, with standard procedure or individualized precautions such as premedication, temporally separated single injections, alternative brand, and/or administration in hospital with full strength or graded doses according to published protocols. In cases of serious AEFI or CI, indicating temporary suspension or exemption, vaccination was not recommended.…”